Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Sayegh

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Cancers|November 14, 2023
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural AreasHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
Heliyon|September 19, 2022
A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancersHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
Scandinavian Journal of Urology|February 10, 2021
Urodynamics in patients with multiple sclerosis: is it necessary? A randomized-controlled trialElie El Helou, Julien Sarkis, Georges Mjaess, et al.
CA: a Cancer Journal for Clinicians|January 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitorsChadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, et al.
Journal of Kidney Cancer and VHL|August 5, 2024
Clinical, Genomic, and Transcriptomic Characteristics of Patients with Metastatic Renal Cell Carcinoma Who Developed Thromboembolic EventsGliceida Galarza Fortuna, Beverly Chigarira, Vinay Mathew Thomas, et al.
European Urology Focus|July 14, 2022
Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis-Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-Resistant Prostate Cancer SettingNicolas Sayegh, Nishita Tripathi, Roberto H Nussenzveig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2025
Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate CancerChadi Hage Chehade, Ryon P Graf, Zeynep Irem Ozay, et al.
Biomedicines|December 23, 2022
Detection of <i>BRCA1</i>, and <i>BRCA2</i> Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World SettingTaylor Ryan McFarland, Vinay Mathew Thomas, Roberto Nussenzveig, et al.
Molecular Cancer Therapeutics|October 5, 2022
External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate CancerUmang Swami, Nicolas Sayegh, Yeonjung Jo, et al.
Clinical Genitourinary Cancer|February 7, 2022
Histologic Growth Patterns in Clear Cell Renal Cell Carcinoma Stratify Patients into Survival Risk GroupsDeepika Sirohi, Jonathan Chipman, Marc Barry, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Cancers|November 14, 2023
Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural AreasHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
Heliyon|September 19, 2022
A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancersHaoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, et al.
Scandinavian Journal of Urology|February 10, 2021
Urodynamics in patients with multiple sclerosis: is it necessary? A randomized-controlled trialElie El Helou, Julien Sarkis, Georges Mjaess, et al.
CA: a Cancer Journal for Clinicians|January 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitorsChadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, et al.
Journal of Kidney Cancer and VHL|August 5, 2024
Clinical, Genomic, and Transcriptomic Characteristics of Patients with Metastatic Renal Cell Carcinoma Who Developed Thromboembolic EventsGliceida Galarza Fortuna, Beverly Chigarira, Vinay Mathew Thomas, et al.
European Urology Focus|July 14, 2022
Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis-Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-Resistant Prostate Cancer SettingNicolas Sayegh, Nishita Tripathi, Roberto H Nussenzveig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2025
Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Prostate CancerChadi Hage Chehade, Ryon P Graf, Zeynep Irem Ozay, et al.
Biomedicines|December 23, 2022
Detection of <i>BRCA1</i>, and <i>BRCA2</i> Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World SettingTaylor Ryan McFarland, Vinay Mathew Thomas, Roberto Nussenzveig, et al.
Molecular Cancer Therapeutics|October 5, 2022
External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate CancerUmang Swami, Nicolas Sayegh, Yeonjung Jo, et al.
Clinical Genitourinary Cancer|February 7, 2022
Histologic Growth Patterns in Clear Cell Renal Cell Carcinoma Stratify Patients into Survival Risk GroupsDeepika Sirohi, Jonathan Chipman, Marc Barry, et al.
Pageof 8